Source Name: HCG Cancer Hospital
Category name: General
HCG Cancer Hospital Bengaluru Sets New Benchmark in Personalized Cancer Care with the Launch of India’s First Innovative ‘Ethos™’ Therapy, an AI-Based Adaptive Radiation Therapy
Bangalore, October 29, 2022 – In order to provide patients with access to world-class treatment facilities and to be committed to high quality clinical care, HCG Cancer Hospital, Bengaluru, one of the largest hospitals in India dedicated to cancer care cancer, announced the launch of India’s first Varian Ethos™ therapy, a holistic AI-based artificial intelligence solution designed to increase the capacity, flexibility and efficiency of radiation therapy. This new solution is designed to provide full adaptive processing in a typical 15 minute time window. It uses augmented intelligence, a convergence of people and artificial intelligence (AI) working together for better results. This breakthrough radiation therapy personalizes cancer care using adaptive intelligence based on patient anatomy and tumor position at the time of treatment.
Ethos™ therapy, the first of its kind in India and a new technique in the world, offers the possibility to modify the treatment plan according to tumor and anatomical changes. This unique technology can capture movement of internal or external anatomy during each treatment and improve their pre-treatment plans by allowing them insight through the advanced power of image segmentation and treatment planning enhanced by the AI. It also applies automated dose accumulation to predict and monitor treatment progress and improves treatment capacity by rendering personalized and targeted radiation that yields better results with minimized side effects. The system allows clinicians to efficiently deliver a complete personalized treatment within a 15-minute time window, which is significantly shorter than other treatment systems that take over 40 minutes, often due to manual treatment reconfiguration.
Talking about technology Dr BS Ajaikumar, Executive Chairman, HealthCare Global Enterprises Ltd, said, “We are pleased to unveil the groundbreaking Ethos™ therapy, a key step in HCG’s pioneering advances toward precision and personalized cancer care. Adaptive therapy is indeed the future of radiation therapy, and Ethos demonstrates our relentless commitment to improving cancer treatment and improving patient outcomes through the adoption of cutting-edge technologies.”
Mr. Raj Gore, CEO, HealthCare Global Enterprises Ltd said, “We are delighted to bring the highly innovative Ethos™ therapy to India through our partnership with Varian. A pioneer in targeted cancer treatments, HCG has always delivered on its promise to “add years to life”. We remain steadfastly committed to reducing the global burden of cancer through a judicious blend of cutting-edge technologies and depth of knowledge, experience and skill.”
(Disclaimer: The above content is a press release. PTI takes no editorial responsibility for it.)